Screener/Healthcare/Biotechnology

ZVRA

Zevra Therapeutics, Inc.NASDAQ
$9.15-0.27 (-2.81%)
$6.19
$13.16
$9.02
$9.35
EPS (TTM)$0.49
P/E Ratio18.67
Dividend Yield
Market Cap$505.8M
Volume496K
Prev Close$9.42
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q3 '25$26.1M-$544K$-0.01-2.1%
Q2 '25$25.9M$74.7M$1.21288.7%
Q1 '25$20.4M-$3.1M$-0.04-15.2%
Q4 '24$12.0M-$35.7M$-0.67-296.8%
Q3 '24$3.7M-$33.2M$-0.69-899.2%
Q2 '24$4.4M-$19.9M$-0.48-447.9%
Q1 '24$3.4M-$16.6M$-0.40-485.3%
Q4 '23$13.2M-$15.2M$-0.4084.9%-114.6%
Get Your Daily Market Recap